TNF and Alzheimer disease: In addition, we noted that patients with MCI showed significantly lower TNF-α and Aβ42 levels than those with AD, indicating that changes in these two signatures might characterize the transition from MCI to AD, and likely identify clinical profiles with the worst outcome of AD.